financetom
Business
financetom
/
Business
/
Hims & Hers Health Unusual Options Activity For February 28
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hims & Hers Health Unusual Options Activity For February 28
Feb 28, 2025 9:04 AM

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health ( HIMS ) .

And retail traders should know.

We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.

Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HIMS, it often means somebody knows something is about to happen.

So how do we know what these investors just did?

Today, Benzinga's options scanner spotted 18 uncommon options trades for Hims & Hers Health ( HIMS ).

This isn't normal.

The overall sentiment of these big-money traders is split between 33% bullish and 27%, bearish.

Out of all of the special options we uncovered, 4 are puts, for a total amount of $212,060, and 14 are calls, for a total amount of $1,252,211.

Predicted Price Range

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $40.0 to $100.0 for Hims & Hers Health ( HIMS ) over the recent three months.

Volume & Open Interest Trends

In terms of liquidity and interest, the mean open interest for Hims & Hers Health ( HIMS ) options trades today is 2528.86 with a total volume of 24,378.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Hims & Hers Health's ( HIMS ) big money trades within a strike price range of $40.0 to $100.0 over the last 30 days.

Hims & Hers Health Call and Put Volume: 30-Day Overview

Noteworthy Options Activity:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
HIMS CALL SWEEP BEARISH 02/28/25 $2.32 $2.16 $2.16 $41.50 $345.6K 3.1K 1.8K
HIMS CALL SWEEP BEARISH 02/28/25 $1.74 $1.63 $1.74 $43.00 $139.4K 3.3K 3.7K
HIMS CALL SWEEP NEUTRAL 03/07/25 $5.0 $4.6 $4.8 $40.00 $111.3K 1.1K 445
HIMS CALL TRADE BULLISH 04/04/25 $3.75 $3.25 $3.6 $50.00 $107.6K 692 1.2K
HIMS CALL TRADE BULLISH 02/28/25 $2.52 $2.36 $2.52 $42.00 $106.8K 1.8K 5.8K

About Hims & Hers Health

Hims & Hers Health Inc ( HIMS ) is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.

After a thorough review of the options trading surrounding Hims & Hers Health ( HIMS ), we move to examine the company in more detail. This includes an assessment of its current market status and performance.

Hims & Hers Health's Current Market Status

With a trading volume of 13,836,676, the price of HIMS is down by -2.39%, reaching $40.35.

Current RSI values indicate that the stock is may be approaching overbought.

Next earnings report is scheduled for 66 days from now.

Expert Opinions on Hims & Hers Health

In the last month, 5 experts released ratings on this stock with an average target price of $43.0.

Turn $1000 into $1270 in just 20 days?

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.

* Consistent in their evaluation, an analyst from B of A Securities keeps a Underperform rating on Hims & Hers Health ( HIMS ) with a target price of $21.

* Maintaining their stance, an analyst from Canaccord Genuity continues to hold a Buy rating for Hims & Hers Health ( HIMS ), targeting a price of $68.

* Consistent in their evaluation, an analyst from Citigroup keeps a Sell rating on Hims & Hers Health ( HIMS ) with a target price of $27.

* An analyst from Truist Securities persists with their Hold rating on Hims & Hers Health ( HIMS ), maintaining a target price of $39.

* An analyst from Morgan Stanley downgraded its action to Equal-Weight with a price target of $60.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Hims & Hers Health ( HIMS ) with Benzinga Pro for real-time alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla Stock Is Sliding Thursday: What's Going On?
Tesla Stock Is Sliding Thursday: What's Going On?
Mar 7, 2024
Tesla Inc ( TSLA ) shares are trading lower Thursday, adding to losses of more than 12% for the week. Here’s a look at what’s going on. What To Know: Tesla shares are on pace for their worst week since January when the stock fell after the EV maker reported worse-than-expected results and turned in disappointing delivery numbers for the...
Why Victoria's Secret Stock Is Tumbling Thursday
Why Victoria's Secret Stock Is Tumbling Thursday
Mar 7, 2024
Victorias Secret & Co ( VSCO ) shares are trading lower Thursday on the heels of the company’s mixed fourth-quarter results. JPMorgan downgraded the stock and other analysts lowered price targets following the print. What Happened: Victoria’s Secret reported fourth-quarter revenue of $2.08 billion, which missed consensus estimates of $2.09 billion, per Benzinga Pro. The company reported earnings of $2.58 per share,...
Tesla Ceases Membership of Australia's Federal Chamber of Automotive Industries Over 'False, Misleading' Comments
Tesla Ceases Membership of Australia's Federal Chamber of Automotive Industries Over 'False, Misleading' Comments
Mar 7, 2024
09:22 AM EST, 03/07/2024 (MT Newswires) -- Tesla (TSLA) said Thursday that it will cease its membership of Australia's Federal Chamber of Automotive Industries at the end of 2023/2024 financial year due to false and misleading remarks by the industry organization. The electric vehicle maker raised concerns regarding FCAI's comments about claimed price impact which were demonstrably false, the company...
Akero Therapeutics Insider Sold Shares Worth $2,465,063, According to a Recent SEC Filing
Akero Therapeutics Insider Sold Shares Worth $2,465,063, According to a Recent SEC Filing
Mar 7, 2024
09:20 AM EST, 03/07/2024 (MT Newswires) -- Andrew Cheng, Director, President and CEO, on March 04, 2024, sold 75,000 shares in Akero Therapeutics ( AKRO ) for $2,465,063. Following the Form 4 filing with the SEC, Cheng has control over a total of 591,416 shares of the company, with 591,416 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1744659/000095017024027510/xslF345X03/ownership.xml Price: 29.77, Change: -0.23,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved